Note: This article is a journalistic-style synthesis of real reporting and peer-reviewed research on fake peer review, paper mills, predatory publishing, and medical journal retractions. Source links are omitted by request.
Peer review is supposed to be medicine’s quality-control checkpoint, the part where experts squint at a study and ask, “Does this make sense, or did the statistics wander in here unsupervised?” In theory, it is one of the strongest filters in scientific publishing. In practice, it is still run by human beings, which means it can be rushed, gamed, impersonated, and occasionally dressed up in a fake mustache and waved through the door.
That is the unsettling truth behind sham peer reviews in medicine. These are not merely sloppy reviews or weak editorial decisions. They are manipulated, fabricated, or corrupted reviews designed to make questionable papers look legitimate. Sometimes the fraud is simple: an author suggests a reviewer and quietly supplies an email address that leads right back to the author or an accomplice. Sometimes it is industrial: a paper mill sells not only a manuscript, but also a strategy for getting it published. And sometimes the damage does not stop at publication. Dubious papers can seep into systematic reviews, influence future research, and muddy the waters of evidence-based care.
If that sounds dramatic, it should. Medical publishing is not a hobby club for people who enjoy formatting references at midnight. It shapes clinical decisions, careers, grant funding, public trust, and, in some cases, patient outcomes. When the peer review process is faked, the problem is not just academic embarrassment. It is a crack in the foundation.
What sham peer review actually means
At its core, sham peer review is a counterfeit version of scholarly scrutiny. A paper appears to have been evaluated by independent experts, but that review was never truly independent, and sometimes it was never truly written by an expert at all.
The classic version: fake reviewer identities
For years, many journals allowed or even encouraged authors to suggest potential reviewers. On paper, that was not unreasonable. Authors often know who works in a narrow specialty. But the system created a loophole big enough to drive a questionable manuscript through. Unscrupulous authors or third-party agencies could submit the names of real scientists paired with fake email addresses, or invent reviewers outright. When the journal sent the invitation, the fraudster received it, wrote a glowing review, and sent it back with all the solemn authority of a supposed outside expert.
That is the publishing equivalent of grading your own exam, then complimenting your handwriting.
The evolved version: paper mills and review manipulation
More recent concerns reach beyond a few rogue authors. Paper mills are organizations that manufacture low-quality or fabricated manuscripts for paying clients. Some sell authorship slots. Some recycle data, images, and text templates. Some appear to offer help with reviewer suggestions, citation boosting, and other forms of editorial manipulation. In other words, the fraud can become a service package. Not deluxe, exactly. More like “all-inclusive ethical disaster.”
This is one reason the line between peer review fraud, predatory publishing, and broader research misconduct can blur. They are not identical problems, but they overlap. A sham review can help a weak paper get accepted in a legitimate journal. A predatory journal may claim to perform peer review while barely doing any. A paper mill can exploit either environment.
Why medicine is especially vulnerable
Medicine has everything a fraudster loves: intense publication pressure, high stakes, fragmented subspecialties, global competition, and journals that are often stretched thin. Add in overloaded editors, scarce reviewers, and the constant demand for fresh findings, and you get a system with noble goals and several exposed wires.
There is also a structural issue. In many academic and clinical environments, publication is still treated as currency. It affects promotions, reputation, grant prospects, and institutional standing. That pressure does not make people dishonest by default, but it creates a market for anyone promising a shortcut. The old saying “publish or perish” was once a warning. In the world of sham peer reviews, it sometimes sounds like a business model.
Medicine is also especially exposed because bad papers in this field can echo far beyond the journal issue that first printed them. A flawed lab study may waste time. A fraudulent clinical paper can mislead literature reviews, distort therapeutic conversations, and make weak evidence look stronger than it is.
The retraction waves that forced everyone to pay attention
Sham peer review stopped being a niche concern when publishers began retracting papers in batches large enough to make the scientific community drop its coffee. One publisher retracted 43 papers after investigating suspicious peer review activity. Another later pulled 64 papers across multiple journals after uncovering fake email addresses and fabricated review reports. In one of the most notorious episodes, the cancer journal Tumor Biology retracted 107 papers linked to fake peer review, a scandal large enough to become a landmark case in publication ethics.
These were not isolated typos in editorial paperwork. They were signs that the review process itself had been compromised at scale. And the lesson was uncomfortable: journals did not always need a villain in a trench coat sneaking through a basement window. Sometimes the fraud came through the front door, using normal submission tools and ordinary-looking reviewer forms.
More recently, the problem has evolved rather than vanished. Reporting has described suspicious repeated phrases in peer reviews, suggesting that some reports may be copied, coordinated, or generated from templates. Other reporting has highlighted cases in which real scientists discovered their identities had apparently been used to submit fake reviews. The fraud is no longer just “someone invented a reviewer.” Sometimes it is “someone borrowed a reviewer’s face.”
How sham peer review damages medicine
It contaminates the evidence base
The most alarming part of this story is not the fake review itself. It is what happens after the paper enters the literature. A 2025 study in JAMA Network Open found that although contamination of systematic reviews by retracted paper-mill articles remained relatively low, it was increasing over time. That matters because systematic reviews and meta-analyses are often treated as the top shelf of medical evidence. If fraudulent or sham-reviewed studies are mixed into that evidence stack, the shelf starts wobbling.
And once a bad paper is cited, it gains a second life. It can be copied into future reviews, grant proposals, conference slides, and educational materials. Retraction does not always stop that spread. Sometimes it barely slows it down.
It wastes honest labor
Every fake review steals time from people who are trying to do the job properly. Editors must investigate. Journals must retract. Integrity teams must compare records, email trails, and reviewer histories. Honest reviewers, already working for free in many cases, are left cleaning up a mess they did not create. The scientific record gets corrected, but only after a painful amount of unpaid detective work.
It weakens trust
Medicine depends on trust more than it likes to admit. Clinicians trust journals. Patients trust clinicians. Researchers trust that published methods are at least attached to reality. Sham peer review erodes that trust from the inside. It does not just raise the question, “Was this paper wrong?” It invites the more corrosive question: “Was anyone really checking?”
What fake peer reviews often look like in the wild
By now, editors and research-integrity teams have learned to watch for patterns. No single sign proves fraud, but clusters of red flags can make a manuscript smell less like science and more like a costume party.
Common warning signs
Reviewer email problems: The reviewer is supposedly a leading expert, but the contact address is generic, oddly structured, or unrelated to the institution.
Suspicious speed: A detailed, enthusiastic review arrives with lightning speed, as if the reviewer abandoned all earthly obligations to praise this one manuscript.
Uniform positivity: The report reads like a fan letter, not a critical review. Major flaws go unmentioned. Minor edits are cosmetic.
Template language: Different reviews use strangely similar phrases, structure, or tone across unrelated papers.
Odd authorship patterns: Author groups that do not seem to fit together intellectually or institutionally can sometimes hint at paper-mill activity.
Thin data transparency: Weak raw data access, recycled figures, vague methods, or resistance to post-publication questioning can deepen suspicion.
None of this means peer review is broken beyond repair. It means peer review cannot rely on trust alone. It needs verification.
How journals and publishers are fighting back
The response has become much more sophisticated than it was a decade ago. Many publishers have tightened reviewer verification, reduced reliance on author-suggested reviewers, and built research-integrity teams that work across journals instead of leaving each editor to fight alone with a laptop and a headache.
Identity checks are getting stricter
Journals increasingly verify reviewers through institutional affiliations, persistent identifiers such as ORCID, and publication records. A famous scientist with a random webmail address now raises more eyebrows than before. That may sound obvious, but fraud thrives wherever “obvious” checks are skipped in the interest of speed.
Data transparency matters more than ever
Calls for open data, transparent methods, image screening, and reproducibility checks are not just nice reform slogans. They are practical defenses. Fraudulent publishing becomes harder when the underlying data, methods, and editorial histories are easier to inspect. Transparency will not solve everything, but it makes secrecy work harder for its paycheck.
Cross-publisher cooperation is becoming essential
Paper mills and review manipulation rarely respect journal boundaries, so anti-fraud efforts cannot stay siloed. Publishers, editors, librarians, watchdogs, and indexing services increasingly need to share signals, compare patterns, and act faster when misconduct emerges. A bad paper does not care which logo appears at the top of the PDF.
What clinicians, authors, and readers should do now
For clinicians
Treat even published literature with healthy skepticism, especially when findings are dramatic, weakly replicated, or strangely neat. Check whether key papers have expressions of concern or retractions. Look beyond the abstract. The abstract is often where confidence goes to dress up for dinner.
For authors and trainees
Be wary of unsolicited invitations from journals with suspiciously flattering language, unrealistically fast timelines, or vague editorial details. Do not outsource your scientific conscience to a broker promising publication support. If a service sounds like it can magically handle authorship, submission, and peer review, it is not “support.” It is a trap with a customer service department.
For institutions
Research integrity training needs to move beyond plagiarism slides and awkward online quizzes. Early-career researchers should learn how sham peer review works, how predatory journals operate, and why authorship-for-sale schemes are not victimless shortcuts. Institutions that reward raw publication counts without rewarding quality and transparency are basically leaving snacks out for fraud.
Composite experiences from the front lines
The following section is a composite narrative based on reported patterns, editorial commentary, and documented cases. It is written to reflect the human experience around sham peer review in medicine without claiming to be a single firsthand account.
An editor opens a manuscript on a Tuesday afternoon. The topic is specialized, the reviewer pool is small, and the authors have helpfully suggested three experts. That seems convenient until the first review comes back absurdly fast, glowing with praise, and strangely allergic to criticism. The second review is equally enthusiastic. The third never arrives. At first, the editor feels lucky. Then uneasy. A quick check shows that the “reviewers” are tied to generic email accounts. One of the names belongs to a real scientist who has never heard of the paper. What looked like efficiency now looks like forgery wearing a tie.
A legitimate reviewer has a different kind of experience. She agrees to review a clinical manuscript after a twelve-hour hospital shift because that is how peer review often works: squeezed into the corners of real life. She spends an evening checking methods, comparing tables, and writing detailed comments that may or may not be appreciated. A month later, she hears that another paper in the same field sailed through with suspiciously positive reviews. The feeling is not just frustration. It is insult. Honest reviewers donate expertise to protect the literature, while fake reviewers glide in like uninvited VIPs and get better treatment.
Then there is the junior researcher, ambitious and overpressured, receiving an email from a so-called publication consultant. The promise is smooth: editing help, journal matching, fast handling, better chances of acceptance. Maybe there is a wink about reviewer suggestions. Maybe there is no wink at all, just polished language and a professional-looking website. For someone trapped in a promotion system obsessed with output, the offer can feel less like corruption and more like survival. That is part of what makes the ecosystem dangerous. Fraud rarely introduces itself as fraud. It shows up dressed as career support.
Now picture the scientist whose identity gets hijacked. He learns that his name has been used in peer review reports he never wrote. He did not recommend those papers. He did not evaluate those methods. Yet his reputation has been turned into a borrowed stamp of approval. There is a special kind of violation in that. It is not just impersonation. It is the theft of professional credibility, the kind that takes years to build and seconds to misuse.
Finally, there is the downstream reader: a clinician, guideline writer, or patient advocate trying to make sense of the evidence. They are not part of the publishing drama. They just want reliable science. But they inherit the consequences all the same. A sham-reviewed paper may look polished, indexed, and citable. It may slip into a review, shape a discussion, or reinforce a shaky narrative. By the time the fraud is uncovered, the paper may already have done what bad evidence does best: create confusion that takes much longer to clean up than it did to create.
Conclusion
The hidden world of sham peer reviews in medicine is not hidden because nobody noticed. It stayed hidden because the process it exploited was built on trust, speed, and professional good faith. Those are strengths in a healthy system, but they become weaknesses when bad actors learn how to imitate legitimacy.
The good news is that the problem is no longer invisible. Editors, watchdogs, publishers, and researchers are paying closer attention. Identity checks are tighter. Retractions are more visible. Conversations about research integrity, predatory journals, and paper mills are no longer confined to a few insiders muttering into conference coffee. The bad news is that fraud adapts. It gets more organized, more polished, and more comfortable inside the machinery of scientific publishing.
That means the answer cannot be blind faith in peer review, nor cynical surrender. It has to be better peer review: slower when needed, more transparent where possible, more accountable always, and less vulnerable to fake identities, fake enthusiasm, and fake science in a white coat. Medicine does not need to abandon peer review. It needs to stop treating it like a sacred ritual and start treating it like the security system it was always meant to be.
